OLMA logo

Olema Pharmaceuticals, Inc. Common Stock


OLMA: Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.


Show OLMA Financials

Consumer Interest
SEC Filings

Recent trades of OLMA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by OLMA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Tetrahydro-1h-pyrido [3,4-b]indole anti-estrogenic drugs Jun. 13, 2023
  • Patent Title: Tetrahydro-1h-pyrido [3,4-b]indole anti-estrogenic drugs Jan. 25, 2022
  • Patent Title: Tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs May. 21, 2019
  • Patent Title: Benzopyran compounds, compositions and uses thereof Apr. 28, 2015
  • Patent Title: Substituted triphenyl butenes Nov. 22, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of OLMA in WallStreetBets Daily Discussion


Recent insights relating to OLMA

CNBC Recommendations

Recent picks made for OLMA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OLMA

Corporate Flights

Flights by private jets registered to OLMA